ΔNp63 transcript loss in bladder cancer constitutes an independent molecular predictor of TaT1 patients post-treatment relapse and progression.
Maria-Alexandra PapadimitriouMargaritis AvgerisPanagiotis K LevisTheodoros TokasKonstantinos StravodimosAndreas ScorilasPublished in: Journal of cancer research and clinical oncology (2019)
ΔΝp63 loss is associated with adverse outcome of NMIBC resulting in superior prediction of NMIBC early relapse and progression.